FDA Advisory Committee Review of 2021
Eye on FDA
JANUARY 5, 2022
Of note, this tally does not include meetings of the Vaccines and Related Biologic Products Advisory Committee held to consider a recommendation for COVID-19 vaccines, but includes only drugs and biologics. FDA Adcomms have been declining in number even as the agency approves more drugs.
Let's personalize your content